OPTUS Pharmaceutical Co., Ltd. Stock: price and insider trades · South Korea
옵투스제약
No insider purchase over the last 90 days. The latest, by 윤대인, was filed 12 Jun 2026.
OPTUS Pharmaceutical Co., Ltd.: what insiders have been doing
Every trade that managers of OPTUS Pharmaceutical Co., Ltd. disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. In the past year (31 October 2025 to 31 October 2026), 3 filings came from 2 insiders.
Only purchases show up on the open market, 1 purchase in all, filed by 1 insider. The totals exclude 1 filing filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The buyers include 1 chief executive.
Compared with its exchange (2,655 companies, median 7 filings), a count of 3 filings is below the norm. Our records for OPTUS Pharmaceutical Co., Ltd. go back to 2021, with 3 purchases and 2 sales on the open market in total.
The latest purchase dates back some time: it was published 151 days ago, on 12 June 2026.
In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- -13.2%Entry ₩7,290 · Close at T+365 ₩6,330
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 70,000 sharesShareKRXDART:20260612000090Canonical exit: 10 Sept 2026 (T+90)
- ●Executives0DART
- ●Executives0DART
- 183,561 sharesKRXDART:20250709000144
- ●Executives0DART
- ●Executives0DART
- 59,149 sharesKRXDART:20250109000123
- 91,845 sharesKRXDART:20241008000143Canonical exit: 3 Oct 2024 (T+90)
- ●Executives0DART
- ●Executives0DART
- 130,000 shares@ ₩7,397.6154100.0% of flowShareKRXDART:20220510000365Canonical exit: 1 Aug 2022 (T+90)
- ●Executives0DART
- ●Executives0DART
13 of 13 declarations
About OPTUS Pharmaceutical Co., Ltd.
Optus Pharmaceutical is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on the development and distribution of pharmaceutical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
